Search - tctmd.com

Displaying 761 - 780 of 1171

Sort: Relevancy | Date

News Industry News

Abiomed Impella 2.5 Receives FDA Approval for Elective and Urgent High Risk Percutaneous Coronary Intervention (PCI) Procedures

March 23, 2015

News Conference News ACC 2015

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Todd Neale

March 20, 2015

News Conference News ACC 2015

DANAMI3-PRIMULTI: Complete Revascularization Improves Outcomes for STEMI

Yael L. Maxwell

March 17, 2015

News Conference News ACC 2015

ERICCA: Remote Ischemic Preconditioning Fails to Improve Long-Term Outcomes After CABG

Yael L. Maxwell

March 16, 2015

News Conference News ACC 2015

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

L.A. McKeown

March 16, 2015

News Conference News ACC 2015

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

Yael L. Maxwell

March 15, 2015

News Conference News ACC 2015

Outcomes at 5 Years Reinforce Durability of Stenting for Unprotected Left Main Disease

L.A. McKeown

March 15, 2015

News Conference News ACC 2015

Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients

Todd Neale

March 14, 2015

News Daily News

Analysis of SYNTAX Patients Documents Underuse of OMT

L.A. McKeown

March 05, 2015

News Industry News

New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions

February 24, 2015

News Industry News

Medtronic Starts U.S. Launch of IN.PACT Admiral Drug-Coated Balloon for Treatment of Peripheral Arterial Disease in Upper Leg

February 03, 2015

News Daily News

对慢性肾病患者，CABG比PCI的长期效果好

Yael L. Maxwell

January 28, 2015

News Daily News

Michael J. Davidson, Advocate of Surgical-Interventional Cooperation, Dies at 44

Yael L. Maxwell

January 28, 2015

News Daily News

For CKD Patients, CABG Favored Long-term Over PCIEn Pacientes con ERC, la CABG fue Más Favorable a Largo Plazo que la PCI

Yael L. Maxwell

January 28, 2015

News Daily News

For CKD Patients, CABG Favored Long-term Over PCI

Yael L. Maxwell

January 28, 2015

News Daily News

DES With Biodegradable Polymer Safe, Durable Through 5 Years

L.A. McKeown

January 28, 2015

News Daily News

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

L.A. McKeown

January 12, 2015

News Daily News

Coronary Revascularization Performed Less Frequently

Todd Neale

January 12, 2015

News Daily News

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

L.A. McKeown

January 12, 2015

News Daily News

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

L.A. McKeown

January 12, 2015

Advertisement

Abiomed Impella 2.5 Receives FDA Approval for Elective and Urgent High Risk Percutaneous Coronary Intervention (PCI) Procedures

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

DANAMI3-PRIMULTI: Complete Revascularization Improves Outcomes for STEMI

ERICCA: Remote Ischemic Preconditioning Fails to Improve Long-Term Outcomes After CABG

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

Outcomes at 5 Years Reinforce Durability of Stenting for Unprotected Left Main Disease

Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients

Analysis of SYNTAX Patients Documents Underuse of OMT

New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions

Medtronic Starts U.S. Launch of IN.PACT Admiral Drug-Coated Balloon for Treatment of Peripheral Arterial Disease in Upper Leg

对慢性肾病患者，CABG比PCI的长期效果好

Michael J. Davidson, Advocate of Surgical-Interventional Cooperation, Dies at 44

For CKD Patients, CABG Favored Long-term Over PCIEn Pacientes con ERC, la CABG fue Más Favorable a Largo Plazo que la PCI

For CKD Patients, CABG Favored Long-term Over PCI

DES With Biodegradable Polymer Safe, Durable Through 5 Years

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

Coronary Revascularization Performed Less Frequently

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content